Symbol="RVMD"
AssetType="Common Stock"
Name="Revolution Medicines Inc"
Description="Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California."
CIK="1628171"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="700 SAGINAW DR, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3521824000"
EBITDA="-317656992"
PERatio="None"
PEGRatio="None"
BookValue="8.53"
DividendPerShare="0"
DividendYield="0"
EPS="-3.32"
RevenuePerShareTTM="0.314"
ProfitMargin="0"
OperatingMarginTTM="-10.91"
ReturnOnAssetsTTM="-0.236"
ReturnOnEquityTTM="-0.414"
RevenueTTM="29524000"
GrossProfitTTM="-217693000"
DilutedEPSTTM="-3.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.581"
AnalystTargetPrice="34.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="72.24"
PriceToBookRatio="3.162"
EVToRevenue="53.04"
EVToEBITDA="-6.63"
Beta="1.43"
num_52WeekHigh="33.41"
num_52WeekLow="17.03"
num_50DayMovingAverage="28.01"
num_200DayMovingAverage="25.04"
SharesOutstanding="109170000"
DividendDate="None"
ExDividendDate="None"
symbol="RVMD"
open="32.38"
high="32.92"
low="31.68"
price="32.73"
volume="509392.00"
latest_trading_day="2023-08-29"
previous_close="32.26"
change="0.47"
change_percent="1.4569%"
aroon_positive_momentum_days="66"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="66"
Volume_recent_avg="973238"
Change_recent_avg="0.14"
Delta_recent_avg="1.12"
Variance_recent_avg="0.56"
Change_ratio_recent_avg="0.47"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="66"
Aroon_momentum_negative="34"
image_negative_thumbnail_id_1="153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0023.jpeg"
image_negative_thumbnail_id_2="1158"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0192.jpeg"
image_neutral_thumbnail_id_1="598"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_neutral_thumbnail_id_2="579"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_positive_thumbnail_id_1="1001"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0163.jpeg"
image_positive_thumbnail_id_2="681"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0027.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
